Trials / Completed
CompletedNCT01686646
Effects of Two Doses of a Common Cold Treatment on Alertness
Effects of Two Doses of a Common Cold Treatment on Cognitive Function
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate any improvement in alertness and performance based on cognitive function and mood assessment in subjects suffering the common cold, when taking a novel paracetamol and caffeine combination verses paracetamol alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | paracetamol + caffeine | paracetamol with caffeine |
| DRUG | paracetamol | paracetamol |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-09-18
- Last updated
- 2014-12-08
- Results posted
- 2014-07-14
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01686646. Inclusion in this directory is not an endorsement.